Lonza Group Ag (OTCMKTS:LZAGY – Get Free Report) shares passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $63.23 and traded as low as $61.39. Lonza Group shares last traded at $62.41, with a volume of 140,962 shares changing hands.
Wall Street Analyst Weigh In
Separately, Zacks Research upgraded shares of Lonza Group from a “strong sell” rating to a “hold” rating in a report on Wednesday, April 8th. One equities research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, Lonza Group currently has an average rating of “Moderate Buy”.
Read Our Latest Analysis on Lonza Group
Lonza Group Price Performance
About Lonza Group
Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.
The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.
Featured Articles
- Five stocks we like better than Lonza Group
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.
